IBDEI3C0 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,2465,0)
 ;;=ESTABLISHED PATIENT ^1^190
 ;;^UTILITY(U,$J,358.4,2466,0)
 ;;=CONSULTATIONS ^3^190
 ;;^UTILITY(U,$J,358.4,2467,0)
 ;;=NEOPLASMS^9^191
 ;;^UTILITY(U,$J,358.4,2468,0)
 ;;=CARDIOVASCULAR DISORDERS^2^191
 ;;^UTILITY(U,$J,358.4,2469,0)
 ;;=MENTAL HEALTH^8^191
 ;;^UTILITY(U,$J,358.4,2470,0)
 ;;=NEUROLOGICAL CONDITIONS^10^191
 ;;^UTILITY(U,$J,358.4,2471,0)
 ;;=GI DISORDERS^5^191
 ;;^UTILITY(U,$J,358.4,2472,0)
 ;;=LIVER DISORDERS^7^191
 ;;^UTILITY(U,$J,358.4,2473,0)
 ;;=KIDNEY DISORDERS^6^191
 ;;^UTILITY(U,$J,358.4,2474,0)
 ;;=RESPIRATORY DISORDERS^11^191
 ;;^UTILITY(U,$J,358.4,2475,0)
 ;;=PALLIATIVE/HOSPICE ENCOUNTER^1^191
 ;;^UTILITY(U,$J,358.4,2476,0)
 ;;=OTHER CONDITIONS^13^191
 ;;^UTILITY(U,$J,358.4,2477,0)
 ;;=DEMENTIA^3^191
 ;;^UTILITY(U,$J,358.4,2478,0)
 ;;=GENERAL IM^4^191
 ;;^UTILITY(U,$J,358.4,2479,0)
 ;;=OTHER BACTERIAL DISEASES^12^191
 ;;^UTILITY(U,$J,358.4,2480,0)
 ;;=HEALTH/BEHAVIOR ASSESSMENT^1^192
 ;;^UTILITY(U,$J,358.4,2481,0)
 ;;=HEALTH/BEHAVIOR INTERVENTION^2^192
 ;;^UTILITY(U,$J,358.4,2482,0)
 ;;=PC COMMON DIAGNOSES^1^193
 ;;^UTILITY(U,$J,358.4,2483,0)
 ;;=ADMINISTRATIVE TOPICS^15^193
 ;;^UTILITY(U,$J,358.4,2484,0)
 ;;=ANGINA^16^193
 ;;^UTILITY(U,$J,358.4,2485,0)
 ;;=ATHEROSCLEROSIS^17^193
 ;;^UTILITY(U,$J,358.4,2486,0)
 ;;=CARDIOVASCULAR^18^193
 ;;^UTILITY(U,$J,358.4,2487,0)
 ;;=DERMATOLOGY^22^193
 ;;^UTILITY(U,$J,358.4,2488,0)
 ;;=EAR DISORDERS^24^193
 ;;^UTILITY(U,$J,358.4,2489,0)
 ;;=EENT^25^193
 ;;^UTILITY(U,$J,358.4,2490,0)
 ;;=ENDOCRINE/METABOLIC^26^193
 ;;^UTILITY(U,$J,358.4,2491,0)
 ;;=EYE DISORDERS^27^193
 ;;^UTILITY(U,$J,358.4,2492,0)
 ;;=EYE INJURY^28^193
 ;;^UTILITY(U,$J,358.4,2493,0)
 ;;=GASTROENTEROLOGY^29^193
 ;;^UTILITY(U,$J,358.4,2494,0)
 ;;=GU/RENAL^30^193
 ;;^UTILITY(U,$J,358.4,2495,0)
 ;;=HEADACHE^31^193
 ;;^UTILITY(U,$J,358.4,2496,0)
 ;;=HEART VALVE DISEASE^32^193
 ;;^UTILITY(U,$J,358.4,2497,0)
 ;;=HEMATOLOGY/ONCOLOGY^33^193
 ;;^UTILITY(U,$J,358.4,2498,0)
 ;;=HISTORY OF ILLNESS^34^193
 ;;^UTILITY(U,$J,358.4,2499,0)
 ;;=INFECTIOUS DISEASE^35^193
 ;;^UTILITY(U,$J,358.4,2500,0)
 ;;=LIVER DISEASE^36^193
 ;;^UTILITY(U,$J,358.4,2501,0)
 ;;=MENTAL HEALTH^38^193
 ;;^UTILITY(U,$J,358.4,2502,0)
 ;;=MOVEMENT DISORDERS^39^193
 ;;^UTILITY(U,$J,358.4,2503,0)
 ;;=MUSCULOSKELETAL^40^193
 ;;^UTILITY(U,$J,358.4,2504,0)
 ;;=NEUROLOGY^41^193
 ;;^UTILITY(U,$J,358.4,2505,0)
 ;;=PAIN^42^193
 ;;^UTILITY(U,$J,358.4,2506,0)
 ;;=PREVENTIVE HEALTH^43^193
 ;;^UTILITY(U,$J,358.4,2507,0)
 ;;=PULMONARY^44^193
 ;;^UTILITY(U,$J,358.4,2508,0)
 ;;=SEXUAL TRAUMA^45^193
 ;;^UTILITY(U,$J,358.4,2509,0)
 ;;=SIGNS,SYMPTOMS,CONDITIONS^46^193
 ;;^UTILITY(U,$J,358.4,2510,0)
 ;;=SPRAIN/STRAIN-INITIAL ENCOUNTER^47^193
 ;;^UTILITY(U,$J,358.4,2511,0)
 ;;=SUBSTANCE DISORDERS^48^193
 ;;^UTILITY(U,$J,358.4,2512,0)
 ;;=VARICOSE VEINS^50^193
 ;;^UTILITY(U,$J,358.4,2513,0)
 ;;=WOMEN'S HEALTH^51^193
 ;;^UTILITY(U,$J,358.4,2514,0)
 ;;=WOUNDS-INITIAL ENCOUNTER^52^193
 ;;^UTILITY(U,$J,358.4,2515,0)
 ;;=COMA^20^193
 ;;^UTILITY(U,$J,358.4,2516,0)
 ;;=CAUSES OF INJURY^19^193
 ;;^UTILITY(U,$J,358.4,2517,0)
 ;;=DEMENTIA^21^193
 ;;^UTILITY(U,$J,358.4,2518,0)
 ;;=LONG TERM CURRENT DRUG THERAPY^37^193
 ;;^UTILITY(U,$J,358.4,2519,0)
 ;;=ACQUIRED ABSENCE OF BODY PART(S)^2^193
 ;;^UTILITY(U,$J,358.4,2520,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^49^193
 ;;^UTILITY(U,$J,358.4,2521,0)
 ;;=ACSC ACUTE KIDNEY FAILURE^3^193
 ;;^UTILITY(U,$J,358.4,2522,0)
 ;;=ACSC ANGINA^4^193
